Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Childress

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Journal of Child and Adolescent Psychopharmacology|May 19, 2023
Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/DexmethylphenidateAnn C Childress, Andrew J Cutler, Maitrey Patel, et al.
Child and Adolescent Psychiatry and Mental Health|December 16, 2010
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the daySharon B Wigal, Scott H Kollins, Ann C Childress, et al.
Child and Adolescent Psychiatry and Mental Health|June 11, 2009
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderSharon B Wigal, Scott H Kollins, Ann C Childress, et al.
CNS Spectrums|July 16, 2008
Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderRobert L Findling, Ann C Childress, Suma Krishnan, et al.
Cancer Investigation|May 8, 2001
Interferon-alpha combined with radiotherapy in the treatment of unresectable melanomaN P Nguyen, S Sallah, C Childress, et al.
Journal of Child and Adolescent Psychopharmacology|January 8, 2013
NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom studySharon B Wigal, Ann C Childress, Heidi W Belden, et al.
Journal of Child and Adolescent Psychopharmacology|March 1, 2022
A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity DisorderAnn C Childress, Eric Lloyd, Steven A Johnson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 1, 1993
The Kids' Eating Disorders Survey (KEDS): a study of middle school studentsA C Childress, T D Brewerton, E L Hodges, et al.
Frontiers in Psychiatry|July 10, 2023
Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorderGreg W Mattingly, Ann C Childress, Andrew J Cutler, et al.
Journal of Child and Adolescent Psychopharmacology|February 22, 2023
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety StudyAnn C Childress, Andrea Marraffino, Andrew J Cutler, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of Child and Adolescent Psychopharmacology|May 19, 2023
Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/DexmethylphenidateAnn C Childress, Andrew J Cutler, Maitrey Patel, et al.
Child and Adolescent Psychiatry and Mental Health|December 16, 2010
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the daySharon B Wigal, Scott H Kollins, Ann C Childress, et al.
Child and Adolescent Psychiatry and Mental Health|June 11, 2009
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderSharon B Wigal, Scott H Kollins, Ann C Childress, et al.
CNS Spectrums|July 16, 2008
Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderRobert L Findling, Ann C Childress, Suma Krishnan, et al.
Cancer Investigation|May 8, 2001
Interferon-alpha combined with radiotherapy in the treatment of unresectable melanomaN P Nguyen, S Sallah, C Childress, et al.
Journal of Child and Adolescent Psychopharmacology|January 8, 2013
NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom studySharon B Wigal, Ann C Childress, Heidi W Belden, et al.
Journal of Child and Adolescent Psychopharmacology|March 1, 2022
A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity DisorderAnn C Childress, Eric Lloyd, Steven A Johnson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 1, 1993
The Kids' Eating Disorders Survey (KEDS): a study of middle school studentsA C Childress, T D Brewerton, E L Hodges, et al.
Frontiers in Psychiatry|July 10, 2023
Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorderGreg W Mattingly, Ann C Childress, Andrew J Cutler, et al.
Journal of Child and Adolescent Psychopharmacology|February 22, 2023
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety StudyAnn C Childress, Andrea Marraffino, Andrew J Cutler, et al.
Pageof 9